Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuronetics, Inc. - Common Stock (NQ:STIM)

1.940 +0.030 (+1.57%)
Streaming Delayed Price Updated: 9:32 AM EDT, May 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Neuronetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Crude Oil Edges Lower; UBS Shares Jump After Q1 Earnings ↗
 
Via Benzinga
News headline image
STIM Stock Earnings: Neuronetics Beats EPS, Beats Revenue for Q1 2024 ↗
STIM stock results show that Neuronetics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
The Company is highlighting stories from adolescents with major depressive disorder on the heels of groundbreaking FDA clearance 
From Neuronetics
Via GlobeNewswire
News headline image
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Lack of early symptom improvement is not predictive of final responder status 
From Neuronetics
Via GlobeNewswire
News headline image
Earnings Outlook For Neuronetics ↗
 
Via Benzinga
News headline image
Top 5 Health Care Stocks That May Plunge In March ↗
As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
News headline image
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
Advancements provide workflow efficiencies for NeuroStar® TMS providers 
From Neuronetics
Via GlobeNewswire
News headline image
Earnings Scheduled For March 5, 2024 ↗
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
Via Benzinga
News headline image
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
Criteria Change Reduces Requirements for Treatment Accessibility 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
New accessory for NeuroStar TMS reduces patient setup steps and improves efficiency for providers 
From Neuronetics
Via GlobeNewswire
News headline image
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
New updates designed to advance practice efficiency and patient outcomes 
From Neuronetics
Via GlobeNewswire
News headline image
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
Technological advances reduce time and increase efficiency for MDD treatment 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
Policy Updates from Magellan and Two Additional Payors Increase Access for 3.2 Million Covered Lives 
From Neuronetics
Via GlobeNewswire
News headline image
Earnings Scheduled For November 7, 2023 ↗
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
Findings confirm strong correlation between the number of TMS treatment sessions completed and improvement in MDD 
From Neuronetics
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
News headline image
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
Portal provides resources to raise awareness around mental health and suicide prevention 
From Neuronetics
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 283 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 210 companies reached new 52-week lows. 
Via Benzinga
News headline image
NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
Award Acknowledges Excellence in Digital Marketing Efforts 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
New automated features elevate the standard of care for NeuroStar® Advanced Therapy practices 
From Neuronetics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  During the Friday's sesion, 157 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 128 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 73 companies reached new 52-week lows. 
Via Benzinga
News headline image
Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans
Policy Updates Impact Nationwide Commercial Plans for 16.8 Million Covered Lives 
From Neuronetics
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.